Supplementary Figure 7 from ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer | Synapse
September 5, 2025Open Access
Supplementary Figure 7 from ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
Key Points
The study reveals significant allelic imbalance in oncogenic mutations in circulating tumor DNA from metastatic urothelial cancer.
Mutations were detected in ctDNA samples, indicating their potential role in tracking tumor dynamics and progression.
This analysis of metastatic urothelial cancer highlights important genetic changes associated with the disease.
Findings emphasize the relevance of ctDNA for understanding tumor heterogeneity in metastatic urothelial cancer patients.
Abstract
Supplementary Figure 7. Allelic imbalance and clonality of oncogenic mutations detected in metastatic urothelial cancer (mUC) circulating tumor DNA (ctDNA).